We are live on
!
Find out more
ARRY
Array Biopharma Inc
ARRY
ARRY
Delisted
ARRY was delisted on the 29th of July, 2019.
208 hedge funds and large institutions have $3.11B invested in Array Biopharma Inc in 2018 Q3 according to their latest regulatory filings, with 22 funds opening new positions, 76 increasing their positions, 71 reducing their positions, and 35 closing their positions.
New
Increased
Maintained
Reduced
Closed
63% more call options, than puts
Call options by funds: $22.2M | Put options by funds: $13.7M
33% more funds holding in top 10
Funds holding in top 10: 6 → 8 (+2)
7% more repeat investments, than reductions
Existing positions increased: 76 | Existing positions reduced: 71
6% less capital invested
Capital invested by funds: $3.31B → $3.11B (-$205M)
7% less funds holding
Funds holding: 223 → 208 (-15)
37% less first-time investments, than exits
New positions opened: 22 | Existing positions closed: 35
Holders
208
Holders Change
-15
Holders Change %
-6.73%
% of All Funds
4.76%
Holding in Top 10
8
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+33.33%
% of All Funds
0.18%
New
22
Increased
76
Reduced
71
Closed
35
Calls
$22.2M
Puts
$13.7M
Net Calls
+$8.56M
Net Calls Change
+$9.79M
Top Buyers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$41.5M |
| 2 |
Millennium Management
New York
|
+$32.4M |
| 3 |
BI
BVF Inc
San Francisco,
California
|
+$24.8M |
| 4 |
State Street
Boston,
Massachusetts
|
+$19.2M |
| 5 |
PCM
Peregrine Capital Management
Minneapolis,
Minnesota
|
+$17.1M |
Top Sellers
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$13.5M |
| 2 |
Morgan Stanley
New York
|
-$10.1M |
| 3 |
Renaissance Technologies
New York
|
-$9.07M |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
-$8.61M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$7.6M |
